Press Releases
Search
-
17 Sep 2007
bioMérieux and Ipsen Sign Theragnostics Agreement to Develop Companion Test for New Breast Cancer Treatment
Marcy l’Étoile and Paris (France) - Sept. 17, 2007. bioMérieux and Ipsen announce today that they have signed an agreement by which bioMérieux will develop a companion test for a new breast cancer dru...
-
12 Sep 2007
bioMérieux Acquires the Australian BTF, Strengthening its Leadership Position in Industrial Microbiology
Marcy l'Etoile, France - September 12, 2007. As world leader in the field of industrial microbiology, bioMérieux (Euronext: BIM) will bring solutions integrating BTF’s innovative technology to a wide ...
-
06 Sep 2007
bioMérieux, première entreprise en Rhône-Alpes à obtenir des Certificats d’économies d’énergie
Marcy l'Etoile, France - September 6, 2007. bioMérieux S.A. (Euronext : BIM) a été certifié par la DRIRE pour des opérations d’économies d’énergie. bioMérieux est ainsi l’une des premières entreprises...
-
08 Aug 2007
Accord transactionnel entre bioMérieux et Becton, Dickinson dans le domaine de la détection des staphylocoques dorés résistants à la méthicilline
Marcy l'Etoile, France - August 8, 2007 . bioMérieux S.A. (Euronext: BIM) announced today that it has concluded a settlement on several licence agreements with GeneOhm Sciences Canada, a subsidiary of...
-
27 Jul 2007
First–Half 2007 - Sales Up 6.7% Like-For-Like
Marcy l'Etoile, France - July 27, 2007. bioMérieux (Euronext: BIM), a global leader in the field of in vitro diagnostics, today released its business review for the first six months of 2007. Because t...
-
24 Jul 2007
bioMérieux lance le premier test automatisé de détection des toxines A et B de Clostridium difficile
July 24, 2007. A new, rapid, and effective solution in the fight against hospital-acquired (nosocomial)infections. bioMérieux, a world leader in the field of in vitro diagnostics, (Euronext : BIM) has...